Synthetic compound reverses mutant p53 aggregate accumulation, study shows

[News]

Cancer is a multidisciplinary disease, with different mutations leading to different prognoses and treatment necessities. Among the most important mutation targets in cancers, affecting more than 50% of all cancer cases, is TP53.

More... (https://www.news-medical.net/news/20190114/Synthetic-compound-reverses-mutant-p53-aggregate-accumulation-study-shows.aspx)